Investors & Media

Press Releases



All Releases
View Summary TG Therapeutics and Rhizen Pharmaceuticals Announce Global Agreement for Development and Commercialization of Novel PI3K Delta Selective Inhibitor, TGR-1202
Aug 16, 2012
PDF 49.5 KB Add to Briefcase
View Summary TG Therapeutics, Inc. Announces Investigational New Drug (IND) for TGTX-1101, Receives Clearance by the FDA to Commence Clinical Trials in the U.S.
May 14, 2012
PDF 12.8 KB Add to Briefcase
View Summary Manhattan Pharmaceuticals, Inc. Announces Name Change to TG Therapeutics, Inc. and Reverse Stock Split
Apr 27, 2012
PDF 44.5 KB Add to Briefcase
View Summary TG Therapeutics Completes Licensing Agreement With LFB Biotechnologies for the Development of Ublituximab
Mar 2, 2012
PDF 32.1 KB Add to Briefcase
Showing 181-184 of 184 Page: 1 ... 6 7 8 9 10  Previous 20
Add to Briefcase = add release to Briefcase